1671 related articles for article (PubMed ID: 29793327)
1. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
Xie C; Chen B; Wu B; Guo J; Cao Y
Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327
[TBL] [Abstract][Full Text] [Related]
2. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
Li G; Liu K; Du X
Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
[TBL] [Abstract][Full Text] [Related]
3. Silencing of long noncoding RNA SBF2-AS1 inhibits proliferation, migration and invasion and contributes to apoptosis in osteosarcoma cells by upregulating microRNA-30a to suppress FOXA1 expression.
Dai JH; Huang WZ; Li C; Deng J; Lin SJ; Luo J
Cell Cycle; 2019 Oct; 18(20):2727-2741. PubMed ID: 31432728
[No Abstract] [Full Text] [Related]
4. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p.
Cao J; Han X; Qi X; Jin X; Li X
Int J Oncol; 2017 Oct; 51(4):1115-1123. PubMed ID: 28902349
[TBL] [Abstract][Full Text] [Related]
5. LncRNA LINC00313 Knockdown Inhibits Tumorigenesis and Metastasis in Human Osteosarcoma by Upregulating FOSL2 through Sponging miR-342-3p.
Chen H; Wahafu P; Wang L; Chen X
Yonsei Med J; 2020 May; 61(5):359-370. PubMed ID: 32390359
[TBL] [Abstract][Full Text] [Related]
6. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA taurine up regulated 1 promotes osteosarcoma cell proliferation and invasion through upregulating Ezrin expression as a competing endogenous RNA of micro RNA-377-3p.
Yao Q; Li Y; Pei Y; Xie B
Bioengineered; 2022 Jan; 13(1):1767-1778. PubMed ID: 35012433
[TBL] [Abstract][Full Text] [Related]
8. LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway.
Zhang B; Yu L; Han N; Hu Z; Wang S; Ding L; Jiang J
Biomed Pharmacother; 2018 Nov; 107():270-282. PubMed ID: 30098545
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA
Li S; Zheng K; Pei Y; Wang W; Zhang X
Aging (Albany NY); 2019 Dec; 11(23):11609-11623. PubMed ID: 31801112
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA TUG1 contributes to tumorigenesis of human osteosarcoma by sponging miR-9-5p and regulating POU2F1 expression.
Xie CH; Cao YM; Huang Y; Shi QW; Guo JH; Fan ZW; Li JG; Chen BW; Wu BY
Tumour Biol; 2016 Nov; 37(11):15031-15041. PubMed ID: 27658774
[TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA Taurine-Upregulated Gene1 (TUG1) Promotes Tumor Growth and Metastasis Through TUG1/Mir-129-5p/Astrocyte-Elevated Gene-1 (AEG-1) Axis in Malignant Melanoma.
Long J; Menggen Q; Wuren Q; Shi Q; Pi X
Med Sci Monit; 2018 Mar; 24():1547-1559. PubMed ID: 29543785
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of TUG1/miRNA-299-3p Axis Represses Pancreatic Cancer Malignant Progression via Suppression of the Notch1 Pathway.
Xu K; Zhang L
Dig Dis Sci; 2020 Jun; 65(6):1748-1760. PubMed ID: 31655908
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
Gou L; Zou H; Li B
Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
[TBL] [Abstract][Full Text] [Related]
14. LncRNA GAS5 Suppresses the Proliferation and Invasion of Osteosarcoma Cells via the miR-23a-3p/PTEN/PI3K/AKT Pathway.
Liu J; Chen M; Ma L; Dang X; Du G
Cell Transplant; 2020; 29():963689720953093. PubMed ID: 33121268
[TBL] [Abstract][Full Text] [Related]
15. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
Shi J; Tan S; Song L; Song L; Wang Y
Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
[TBL] [Abstract][Full Text] [Related]
16. The Lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell Proliferation, Migration and EMT Phenotype Formation Through Sponging Mir-382.
Zhao L; Sun H; Kong H; Chen Z; Chen B; Zhou M
Cell Physiol Biochem; 2017; 42(6):2145-2158. PubMed ID: 28813705
[TBL] [Abstract][Full Text] [Related]
17. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X
Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of TUG1 by shRNA inhibited renal cell carcinoma formation by miR-299-3p/VEGF axis in vitro and in vivo.
Li Y; Zheng D; Pan L; Dai Y; Cai S; Zhao L; Zhu H
Eur J Pharmacol; 2019 Oct; 860():172536. PubMed ID: 31310753
[TBL] [Abstract][Full Text] [Related]
19. LncRNA ADPGK-AS1 regulated cell proliferation, invasion, migration and apoptosis via targeting miR-542-3p in osteosarcoma.
Luo XF; Wu XJ; Wei X; Wang AG; Wang SH; Wang JL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8751-8760. PubMed ID: 31696461
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA SNHG5 sponges miR-26a to promote the tumorigenesis of osteosarcoma by targeting ROCK1.
Wang Z; Wang Z; Liu J; Yang H
Biomed Pharmacother; 2018 Nov; 107():598-605. PubMed ID: 30114643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
